Pérdida de grasa y metabolismo Pérdida de grasa

Tirzepatida

Also known as: GIP/GLP-1

Doble agonista GIP + GLP-1.

~5 días (dosis semanal)

Common Protocol

Rangos citados: titulación semanal (p. ej. 2.5 → 15 mg/semana).

Science & Mechanism

Doble agonista de los receptores GIP y GLP-1, estudiado por efectos sobre glucosa, apetito y pérdida de peso, a menudo superiores a GLP-1 solo.

Members feature

Join the community from $7/mo to unlock it.

See plans
Legal Notice: This information is strictly educational and is based on scientific and research literature. For research purposes only. The protocols, dose ranges and variations reflect figures cited in scientific discussions and do not constitute medical recommendations. Always consult a qualified healthcare professional.

Related Peptides